Feedback    Advertise    Submit Papers    Reprints    About    Help    Contact   
Upstream Processing Downstream Processing Manufacturing Analytical Facilities
Archive by Issue Archive by Article Type Supplements
CMC Forum Press Releases
Optimum Prefilter Selection and Filter Train Sizing for Media Filtration
Chris Sullivan, Mandar Dixit
BioProcess International, Vol. 8, No. 7, July–August 2010, p. 134
 



The use of 0.1-µm rated sterilizing grade filters has been increasing in cell culture media filtration due to mycoplasma contamination concerns. Currently, no standards exist for conducting mycoplasma retention testing on these 0.1-µm labeled filters. A task force has been established at PDA to publish a technical report to standardize testing. Until such guidelines are published, conducting side-by-side tests under identical conditions is the only fair way to compare different 0.1-µm rated filters. Sartorius Stedim Biotech has conducted such tests on its Sartopore® 2 0.2/0.1 PES 10” cartridge filters at a third party lab using a modified ASTM F838-05 method to show A. Laidlawii removal at LRV = 7/cm2.

Such mycoplasma-retentive filters usually have tight final membrane layers, and a high-performance prefilter is usually required to optimize the filter train. SSB has recently launched a new line of PES prefilters: Sartoguard®. These Prefilters are available in double layer PES as well as triple layer configuration with depth filters such as GF upstream. a combination of Sartoguard® 0.1 nominal → Sartopore® 2 0.2/0.1 has been tested into two media applications: the most common soy-hydrolysate supplemented serum-free media and the strategically important fully chemically defined media. These tests were conducted on 47-mm disks with Pre → Final filters in series under 25 psig constant upstream pressure. Media were prepared from powder in accordance with manufacturer's instructions.

For the serum-free soy hydrolysate supplemented media, all Sartoguard® filters performed very well with v∞ values > 6,000 L/m2. Sartoguard® GF was the best prefilter with v∞~18,000 L/m2, indicating flow-rate driven filtration. The number of 10” elements needed was also calculated for each media assuming 5,000 l batch size and two-hour filtration time. Sartoguard® GF/PES → Sartopore 2 0.1 were the best combinations overall, with 1-30” filter needed for each stage. A leading competitive combination required 2-30” filters for each stage (Figure 1).



The second media tested was a fully chemically defined media with high lipid content. As expected, this media was more difficult to filter. All combinations except Sartoguard® PES exhibited v∞ values > 1,000 L/m2 (~6× less than previous media), indicating throughput driven filtration. Sartoguard® GF was the lead prefilter candidate once again closely followed by Sartoguard® PP and the competitive combination with v8 ~1,000–1,400 L/m2. Number of 10” elements needed for 5,000 l batch size for Sartoguard® GF → Sartopore® 2 0.1 was 17 each followed by 18 each for Sartoguard® PP → Sartopore® 2 0.1, and 19 each for the leading competitive combination (Figure 2).



In conclusion, Sartoguard® 0.1-µm nominal prefilters showed outstanding performance in two different types of cell culture media filtration applications in upstream processing. An application-specific approach of employing different versions of Sartoguard® prefilters proved to be successful as well. We would like to acknowledge SAFC Biosciences for providing different catalogued formulations for this testing.

Author Details
Chris Sullivan is an applications specialist, and Mandar Dixit is head of product management for filtration technologies in North America, Sartorius Stedim Biotech; mandar.dixit@sartorius-stedim.com.

 
| | Share
Biopharmaceutical Production
Facility Design Strategies for Single-Use Technologies

Please join us for a free webinar addressing strategies for facility design in biopharmaceutical manufacturing:

Wednesday, 29 February 2012
8:00 AM and 1:00 PM EST

Presented by:

Ingrid Long, MSc
Research Engineer
GE Healthcare Life Sciences

Register today!

During the webinar, Ms. Long will discuss the impact of different strategies for facility design, with a focus on the following topics:

* Replacement of traditional equipment with the single-use equivalent
* Biopharmaceutical manufacturing in a single room
* Benefits of facility design with respect to cost, risk, and flexibility

Register today!


Nine Conferences — One Location: Hilton Bayfront (San Diego, CA)
Webinars   
Subscribe   
Reprints   
Contact   
About   
Informa plc
©2002 - 2009 BioProcess International
Ph: 508-616-5550